Tildrakizumab maintained a favorable safety profile through 208 weeks in patients with psoriatic arthritis, with no new safety signals reported. Abstracts show that institutions can make internal ...
ARLINGTON, Va. – For many Guard members, 2025 was a busy year. Soldiers and Airmen deployed overseas. They took part in missions along the southern border. Teams responded to natural disasters and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback